• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Federer-backed shoemaker On aims for over $6 billion valuation in U.S. IPO

September 7, 2021 by David Barret Leave a Comment

September 7, 2021

(Corrects valuation to “over $6 bln” from “over $12 bln” in headline and paragraph 1)

(Reuters) – On Holding AG, a shoe firm backed by Swiss tennis star Roger Federer, is targeting a valuation of more than $6 billion in a U.S. initial public offering (IPO), a regulatory filing https://ift.tt/3BMEd5d showed on Tuesday.

The company plans to sell 31.1 million shares in the IPO, priced between $18 and $20 per share. It would raise $622 million at the top end of the price range.

Reuters had reported https://ift.tt/3y5LKtv in April that the shoemaker was targeting a listing in autumn that could fetch it a valuation of between $4 billion and $6 billion.

On’s existing shareholders are offering around 5.66 million shares in the IPO. The company will not get any proceeds from the sale of those shares.

The Zurich-based company was founded in 2010 by Olivier Bernhard, David Allemann and Caspar Coppetti. Federer invested in the company in 2019, according to the filing.

Goldman Sachs & Co, Morgan Stanley and J.P. Morgan are among the underwriters for the offering. On plans to list on the New York Stock Exchange under the symbol “ONON.”

(Corrects valuation to “over $6 bln” from “over $12 bln” in headline and paragraph 1)

(Reporting by Sohini Podder in Bengaluru; Editing by Krishna Chandra Eluri and Aditya Soni)

Source Link Federer-backed shoemaker On aims for over $6 billion valuation in U.S. IPO

David Barret
David Barret

Related posts:

  1. UK card spending slips to 93% of pre-COVID level – ONS
  2. Your next smartwatch could come with not one, but two cameras on board
  3. GM to cut North American production, citing chip shortage
  4. Fujifilm confirms it’s working on high-resolution mirrorless cameras

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Breakthrough Listen Searched Interstellar Object 3I/ATLAS For Technosignatures During Its Closest Approach To Earth
  • “Miracle” Rhinoceros Calf’s Chonky Weight Gain Offers Hope For Species
  • Would You Swap Your Festive Feast For Something Plant-Based Or Lab-Grown?
  • Rodents In The US Are Rapidly Evolving Right “Under Your Nose”
  • 39-Year-Old Discovers Raisins Don’t Come From A Raisin Tree, Gets Mercilessly Roasted By Family And The Internet
  • Hundreds Of 19th-Century Black Leather Shoes Have Mysteriously Washed Up On A Beach
  • What’s Behind The “Florida Skunk Ape” Sightings? A Black Bear, Or Something Else?
  • Hubble Telescope’s Bite Of Dracula’s Chivito Reveals Chaos In The Largest Known Planet-Forming Disk
  • All Animals, Plants, And Fungi On Earth Can Be Traced Back To A Common Ancestor: The “Asgardians”
  • The Only Known (Nearly) Complete Green Mummy Just Revealed Why It’s So Green
  • What Happened To The Vasa? Arguably The Least Successful Ship In History
  • Decorating Your Home With Seasonal Plants? They Could Be A Holiday Hazard For Pets
  • The 9th Dedekind Number: Why It Took 32 Years To Find, And Why We May Never See A 10th
  • Alaska Saw More Wildfires In The Last Century Than In The Previous 3,000 Years
  • If Bird Flu Spills Over To Humans,This Is What Would Happen In A Very Short Period
  • This Unusual Plant Might Be One Of Evolution’s “Weirdest Experiments”
  • In 1940, A Dog Investigated A Hole In A Tree And Discovered A Vast Cave Filled With Ancient Human Artwork
  • “Time Is Not Broken”: US Officials Work To Correct Time, After Discovering It Is 4.8 Microseconds Out
  • The Evolutionary Reason Why Rage Bait Affects Us – And How To Deal With It This Holiday Season
  • Whales Living To 200 May Actually Be The Norm – There’s A Sad Reason Why We Don’t Know Yet
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version